Back to POLEN CAPITAL MANAGEMENT LLC POLEN CAPITAL MANAGEMENT LLC

REGNREGN
14 quarters

Position history for POLEN CAPITAL MANAGEMENT LLCPOLEN CAPITAL MANAGEMENT LLC's holdings in REGENERON PHARMACEUTICALS

POLEN CAPITAL MANAGEMENT LLC previously held 0 shares of REGN (REGENERON PHARMACEUTICALS), worth $0 as of 2022-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$554.7M

Total Shares Change

-1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q2
Latest
Exited
0
-100.0%
$00.0%$594.32
0
2022-Q1
Decreased
1,383
-28.6%
$966,0000.0%$688.56
0
2021-Q4
Decreased
1,938
-10.1%
$1.2M0.0%$638.97
0
2021-Q3
New
2,155
-
$1.3M0.0%$603.35
35
2021-Q1
Exited
0
-100.0%
$00.0%$468.07
0
2020-Q4
Increased
2M
+3.4%
$967.6M2.2%$475.66
57
2020-Q3
Increased
1.9M
+5.0%
$1.1B2.9%$570.45
58
2020-Q2
Increased
1.8M
+7.2%
$1.2B3.5%$607.50
63
2020-Q1
Increased
1.7M
+2.7%
$840.3M3.6%$470.39
60
2019-Q4
Increased
1.7M
+2.1%
$629.4M2.5%$371.64
55
2019-Q3
Increased
1.6M
+3.6%
$455.5M2.1%$271.95
56
2019-Q2
Decreased
1.6M
-1.1%
$496.1M2.4%$311.27
0
2019-Q1
Increased
1.6M
+7.9%
$658M3.4%$408.36
63
2018-Q4
New
1.5M
-
$554.7M3.6%$360.62
87

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used